PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 178 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $826,000 | -65.0% | 64,993 | +6.7% | 0.05% | -66.7% |
Q1 2019 | $2,362,000 | +101.9% | 60,893 | +5.9% | 0.14% | +88.0% |
Q4 2018 | $1,170,000 | -19.5% | 57,493 | +133.8% | 0.08% | +27.1% |
Q2 2018 | $1,454,000 | -48.4% | 24,593 | -40.6% | 0.06% | -47.8% |
Q1 2018 | $2,816,000 | -15.2% | 41,393 | +23.2% | 0.11% | -23.1% |
Q4 2017 | $3,320,000 | +116.0% | 33,590 | +90.9% | 0.15% | +81.5% |
Q2 2017 | $1,537,000 | +97.3% | 17,594 | -30.7% | 0.08% | +76.1% |
Q4 2016 | $779,000 | -10.6% | 25,400 | +95.4% | 0.05% | -83.7% |
Q3 2016 | $871,000 | -25.8% | 13,000 | +14.6% | 0.28% | +354.8% |
Q4 2013 | $1,174,000 | -18.6% | 11,340 | -57.8% | 0.06% | -21.5% |
Q3 2013 | $1,442,000 | +61.1% | 26,880 | +33.3% | 0.08% | +172.4% |
Q2 2013 | $895,000 | – | 20,172 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |